This inventor holds 8 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The Board of Regents of the University of Nebraska, Oncoquest Pharmaceuticals Inc.. Active years: 2004-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 971 
1 out of 1 Years Active: 2004-2021
Title: Michael Anthony Hollingsworth: Innovator in Cancer Treatment
Introduction
Michael Anthony Hollingsworth is a prominent inventor based in Omaha, NE (US), known for his significant contributions to cancer treatment through innovative methods and compositions. With a total of eight patents to his name, Hollingsworth has focused on enhancing the delivery of anti-cancer agents to targeted areas, particularly in solid tumors.
Latest Patents
Among his latest patents, one notable invention is titled "Methods of increasing delivery of anti-cancer agents to targets." This invention provides compositions and methods aimed at increasing the permeability of the stroma surrounding neoplasms, specifically targeting cancer cells associated with solid tumors. By combining a therapeutic IgE antibody with an anti-cancer agent, this method enhances the delivery of the agent to the tumor site, potentially increasing the tumor's responsiveness to treatment. Another significant patent is the "Method of targeting glycoproteins to treat cancer," which involves using monoclonal antibodies to inhibit tumor growth. This method specifically targets truncated O-glycans on glycoproteins, thereby disrupting pro-survival cell signaling pathways and inhibiting tumor growth.
Career Highlights
Hollingsworth has had a distinguished career, working with reputable institutions such as the University of Nebraska and Oncoquest Pharmaceuticals Inc. His work has been instrumental in advancing cancer treatment methodologies, showcasing his commitment to improving patient outcomes through innovative research.
Collaborations
Throughout his career, Hollingsworth has collaborated with notable colleagues, including Karl Kohlgraf and Tom Caffrey. These partnerships have contributed to the development of his groundbreaking patents and research initiatives.
Conclusion
Michael Anthony Hollingsworth stands out as a key figure in the field of cancer treatment innovation. His patents reflect a deep understanding of the complexities of cancer biology and a commitment to developing effective therapeutic strategies. His work continues to inspire advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile